[Strategies to choose scaffold materials for tissue engineering]

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Current organ failure therapies are insufficient, with transplantation facing donor shortages and immune rejection.
• Tissue engineering presents a viable alternative, necessitating the development of ideal scaffold materials.
• Scaffold materials aim to mimic native tissue structure and function for optimal repair.

Purpose of the Study:

• To review existing tissue engineering scaffold materials and influencing factors.
• To explore strategies for selecting and preparing optimal scaffold materials.
• To present a novel approach for creating multifunctional, biomimetic tissue engineering scaffolds.

Main Methods:

• Review of natural, artificial, and composite scaffold materials.
• Analysis of scaffold surface modification and preparation procedures.
• Development of a poly(L-lactic acid)/poly(ε-caprolactone) biliary stent with sustained cytokine release and cell integration.

Main Results:

• Identified key factors influencing scaffold characteristics: surface modification and preparation procedures.
• Successfully differentiated bone marrow mesenchymal stem cells into bile canaliculi-like cells.
• Fabricated a biliary stent with controlled release of growth factors (bFGF, EGF) and integrated induced cells for tissue-engineered bile duct creation.

Conclusions:

• Optimized scaffold design, including surface modification and controlled release systems, is crucial for effective tissue engineering.
• A multidisciplinary approach combining material science, molecular biology, and engineering is essential for developing ideal scaffolds.
• The developed poly(L-lactic acid)/poly(ε-caprolactone) stent represents a promising strategy for tissue-engineered bile duct regeneration.